NASDAQ: MRNAModerna Inc Stock Ownership - Who owns Moderna?
Insider buying vs selling
Have Moderna Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Stephen Hoge | Pres | 2026-10-15 | 76,452 | $12.21 | $933.48kBuy |
| Stephen Hoge | Pres | 2026-10-15 | 39,145 | $220.72 | $8.64MSell |
| Stephen Hoge | Pres | 2026-10-14 | 450 | $214.15 | $96.37kSell |
| Stephen Hoge | Pres | 2026-10-14 | 76,453 | $12.21 | $933.49kBuy |
| Stephen Hoge | Pres | 2026-10-14 | 38,774 | $213.47 | $8.28MSell |
| James M. Mock | CFO | 2026-10-05 | 704 | $190.01 | $133.77kSell |
| Stephen Hoge | Pres | 2026-09-15 | 76,452 | $12.21 | $933.48kBuy |
| Stephen Hoge | Pres | 2026-09-15 | 40,281 | $146.07 | $5.88MSell |
| Stephen Hoge | Pres | 2026-09-14 | 40,294 | $144.13 | $5.81MSell |
| Stephen Hoge | Pres | 2026-09-14 | 76,453 | $12.21 | $933.49kBuy |
MRNA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when MRNA insiders and whales buy or sell their stock.
MRNA Shareholders
What type of owners hold Moderna Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Noubar Afeyan | 14.64% | 58,454,320 | $11.84B | Insider |
| Stephane Bancel | 4.90% | 19,570,020 | $3.97B | Insider |
| Robert Langer | 2.89% | 11,551,753 | $2.34B | Insider |
| Flagship Ventures Fund IV General Partner LLC | 0.53% | 2,101,703 | $425.87M | Insider |
| Stephen Hoge | 0.49% | 1,948,663 | $394.86M | Insider |
| Lorence H. Kim | 0.30% | 1,202,510 | $243.66M | Insider |
| Paul Sagan | 0.24% | 955,943 | $193.70M | Insider |
| Juan Andres | 0.03% | 125,000 | $25.33M | Insider |
| Shannon Thyme Klinger | 0.02% | 81,340 | $16.48M | Insider |
| James M. Mock | 0.02% | 60,125 | $12.18M | Insider |
MRNA vs Biotech Stocks
Moderna Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.